vTv Therapeutics (VTVT) Enterprise Value Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -402.59% |
| Dec 31, 2025 | -180.37% |
| Sep 30, 2025 | -135.89% |
| Jun 30, 2025 | -133.32% |
| Mar 31, 2025 | -149.05% |
| Dec 31, 2024 | -71.38% |
| Sep 30, 2024 | -54.28% |
| Jun 30, 2024 | -41.69% |
| Mar 31, 2024 | -42.12% |
| Dec 31, 2023 | -28.51% |
| Sep 30, 2023 | -61.29% |
| Jun 30, 2023 | -52.07% |
| Mar 31, 2023 | -74.91% |
| Dec 31, 2022 | -51.19% |
| Sep 30, 2022 | -36.50% |
| Jun 30, 2022 | -27.21% |
| Mar 31, 2022 | -61.79% |
| Dec 31, 2021 | -42.33% |
| Sep 30, 2021 | 18.36% |
| Jun 30, 2021 | 11.09% |
| Mar 31, 2021 | -21.43% |
| Dec 31, 2020 | -13.38% |
| Sep 30, 2020 | -26.72% |
| Jun 30, 2020 | -10.60% |
| Mar 31, 2020 | -19.85% |
| Dec 31, 2019 | -18.70% |
| Sep 30, 2019 | -30.74% |
| Jun 30, 2019 | -21.35% |
| Mar 31, 2019 | -11.65% |
| Dec 31, 2018 | -6.72% |
| Sep 30, 2018 | -45.19% |
| Jun 30, 2018 | 157.09% |
| Mar 31, 2018 | 426.35% |
| Dec 31, 2017 | -35.04% |
| Sep 30, 2017 | 374.96% |
| Jun 30, 2017 | 269.12% |